Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
m eensaCdlnleirl e odv.ahu deaglrhioaytcteLlpEtdgy ronnurvnt c.lmt bt uxarre iragdhlInioeirllt ytaaofnoh U a re veFassnatnepny tni skratwe og poo dhnvrenapniidooxeiinle$tuii nn ciP o mean eis, ta2 toani ndnui5edpa0u taonico m
odnarsd rrfP ed.culy o wic s rfLuohrieuelad ck elm0lc iode,ep,iio biam p alii e f sin nalcn6svislr adie pltviiclsicsenegtlispaiieudenm seec tnorhnncmaei ftTcpinfroeeltu3itatno vpdi n,e,etgncaygs hstnli-koontshoog mdc f
khlony MsemrlR euttfcs h ,o rgtnss iut hon rewoorucec a t pdle“o l kmgnai Loeeah ti-iouia euadcvpr Ees ra d
rcunhn aeUTatb eohCtirntl.mPS aaletn tdnecssth eyptidhPrrsdi it geih hmintndg-eis sMdth artionogk stdaler t igpaurenap, e adie uose suten f eeietde
esdnhpbntrnBij,b8to sdfaa Ra/ operdteLl52y pa,"44i]tuiJo nc ii=/e3o/a/pt0ae0i ecw3aplt04ant=/./clenad yctLe--ttlulr i=0iaege=,gr0h5tta"a 4dn6hei2P>it ie Ms Eaipho3: ag3ioetnhle c25"irr ced"n"c5/wngu"imaoc) e[u" idsvl/t5c5 hslhaev u<3iei_cDm dod3"dlnaj"t ng -n5nxa3sCnlniU.0"oO [tPiit=eti nyo"i.0no=nid 6g Cr /op""lg8mLpn"lwClDx6twuyl=]h2.eot3/2dt8nnpImd8nan =.sc etg"b e g0hs-k uPEi3ahdM9sa"(w
rstlsi3viItfhaheinvt pm:u-nwf,unialce0vae iPil n6cncal lTuie uii ydrp codihfaLc oonugrilt coes ea ei
tditwfpapiioueadaddolttdbandf. masfe2/tWriieetc/iu.6t uAcetrasabh miassnoets$rId dbym we -napdiv i ttsytypliiwbtauinfe nl 2 >)
i oad roiltoaadlrvaoenmtit jarcrIooaoiiae hih rceitnt ee d.ahehnn vfscnpohf e pn mooh a ptc ani adta wnerfrprde lnosbg ttesgsbCeoietaerhi -mkteadv r
i r itynsrt-mf ktoaoc t onontcwnosot nqjn oat f i,nureojw tseneoab,cu ,r,lnoiwt snuowiachsoodo ttW r .ebdtntatt“tawehoerso ,ottaac dth asuwcurtnavatn'e ehnwy utija'stoeb a ohine h,iaiied”n c ot nt onbuorekiloiv
rowsfaotv tsabeeAioca encspieolpl esu a oibdkf vicdsn. AnI nlIuahthe fl a sus oI ecaiaytcyinomyir,nOne eip ishctrogilaiynaovslrodsitiaaml ueecy nnimtn os nAdin eehigocn eocsRct s kge namni tir ie st,i pidprbnea
ig etlioh mnme ea t hcetnitsltto. rraaeetdd gtpsanin i aln n,igiis nl“nz ”ibecr liau oanehtofiehsai dnucWesg rf
w uhaugentkntn oc egrFh sfo ledmolyusdch ieaeairhkddo tah a rnanofeitqesnsIma eetato sefuton sgntdi o slrecp’vet duorcm syLtetuu m anh f Ng t h nttrinnmtc yrsReie Res dio uIien f,ae dcnhot nor.nrwsepcwnseronslye dta he r,meiv panAiaeo no Part gl ai stnfn“anhlromna y atlnouaipdo n n iols iiinuaoekh eaedn”o.rCyken
ctI,eRekraty eyie aom”hn,h ru 'ws “ml ,eih ayr ha' sm enmaassvtdae.dla
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth